3rd Conference on Retroviruses and Opportunistic Infections Washington, DC - January 28-February 1, 1996

Conf Retroviruses Opportunistic Infect 1996 Jan 28-Feb 1; 3rd:59 (abstract no. 33)

Sasseville G, Smith MM, Mackay C, Ringler DJ, Lackner AA
Division of Comparative Pathology, Harvard Medical School, Southborough, MA.

The initial entry of lentivirus-infected monocytes into the brain and subsequent development of inflammatory foci are mediated by selective recruitment and activation of circulating monocytes. Previously, we have demonstrated upregulated VCAM-1 in brain in SIV/HIV encephalitis. The novel group of chemotactic cytokines, termed chemokines, has a pivotal role in leukocyte activation, including increased adhesion molecule expression, and in directed migration and stimulation of leukocyte effector functions. However, the role of chemokines in the pathogenesis of AIDS encephalitis has not been examined. We utilized the SIV/macaque model of AIDS to examine the role of chemokines in AIDS encephalitis. Brain tissue from 12 rhesus monkeys with histologically confirmed SIV encephalitis was immunostained with monoclonal antibodies against MCP-1, MCP-3, MIP-l α, MIP-1 β RANTES, IL-8 and IP-10. These tissues were compared to those from uninfected (n=6) and SIV-infected (n=6) macaques without encephalitis. In animals with SIV encephalitis there was upregulation of all the chemokines examined, except for IL-8, when compared to nonencephalitic animals. Chemokine expression correlated with monocytic infiltrates, VCAM-1 expression and viral loads in brain. Interestingly, the greatest expression was observed for MCP-1, MIP-1 α, and RANTES, three chemokines reported to increase integrin expression on the surface of monocytes. Our data indicate that chemokines and VCAM-1 are intimately associated with SIV encephalitis and may mediate monocyte recruitment to the brain.

960128
33

Copyright © 1996 - Foundation for Retrovirology and Human Health . Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Foundation for Retrovirology and Human Health.